These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20593303)

  • 1. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.
    Yang H
    Pharm Res; 2010 Sep; 27(9):1759-71. PubMed ID: 20593303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
    Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA
    Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L; Rosch J; Putnam D
    J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
    Biddlestone-Thorpe L; Marchi N; Guo K; Ghosh C; Janigro D; Valerie K; Yang H
    Adv Drug Deliv Rev; 2012 May; 64(7):605-13. PubMed ID: 22178615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
    Gao H; Pang Z; Jiang X
    Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer advances for the central nervous system delivery of therapeutics.
    Xu L; Zhang H; Wu Y
    ACS Chem Neurosci; 2014 Jan; 5(1):2-13. PubMed ID: 24274162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
    Patel MM; Patel BM
    CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
    Dilnawaz F; Sahoo SK
    Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood-brain barrier.
    Tan Q; Zhao S; Xu T; Wang Q; Lan M; Yan L; Chen X
    J Mater Chem B; 2022 Nov; 10(45):9314-9333. PubMed ID: 36349976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting central nervous system pathologies with nanomedicines.
    Mizrahy S; Gutkin A; Decuzzi P; Peer D
    J Drug Target; 2019; 27(5-6):542-554. PubMed ID: 30296187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S; Gelperina S; Kreuter J
    J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver.
    Cormode DP; Skajaa GO; Delshad A; Parker N; Jarzyna PA; Calcagno C; Galper MW; Skajaa T; Briley-Saebo KC; Bell HM; Gordon RE; Fayad ZA; Woo SL; Mulder WJ
    Bioconjug Chem; 2011 Mar; 22(3):353-61. PubMed ID: 21361312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.
    Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
    Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.
    Mahajan SD; Roy I; Xu G; Yong KT; Ding H; Aalinkeel R; Reynolds J; Sykes D; Nair BB; Lin EY; Prasad PN; Schwartz SA
    Curr HIV Res; 2010 Jul; 8(5):396-404. PubMed ID: 20426757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.